LT2003017A
Polymorphs of an epothilone analog
Abstract
There are provided in accordance with the present invention two crystalline polymorphs, designated Form A and Form B, respectively, of an epothilone analog represented by formula (I). Also provided are methods of forming the novel polymorphs and pharmaceutical dosage forms containing them.
Term
Term ended
Projected expiry passed 25 February 2023, 3.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
70 members in 42 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 22559000 | United States of America | P | |
| 22559000 | United States of America | P | |
| 60225590 | – | – | – |
| US20000225590P | – | – | – |
Members70
| Document | Office | Kind | |
|---|---|---|---|
| CA2418109A1 | Canada | A1 | |
| WO0214323A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU8108201A | Australia | A | |
| UY26886A1 | Uruguay | A1 | |
| PE20020290A1 | Peru | A1 | |
| WO0214323A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2002188014A1 | United States of America | A1 | |
| IS6714A | Iceland | A | |
| NO20030707D0 | Norway | D0 | |
| KR20030022411A | Republic of Korea | A | |
| NO20030707L | Norway | L | |
| HRP20030190A2 | Croatia | A2 | |
| EP1309597A2 | European Patent Office (EPO) | A2 | |
| SI21100A | Slovenia | A | |
| IL153993D0 | Israel | D0 | |
| HK1052010A1 | Hong Kong, China | A1 | |
| SK1342003A3 | Slovakia | A3 | |
| HU0300826A2 | Hungary | A2 | |
| BG107467A | Bulgaria | A | |
| LV13032B | Latvia | B | |
| CN1468243A | China | A | |
| CZ2003418A3 | Czechia | A3 | |
| US6689802B2 | United States of America | B2 | |
| AR034259A1 | Argentina | A1 | |
| BR0113234A | Brazil | A | |
| JP2004506638A | Japan | A | |
| LT2003017AThis record | Lithuania | A | |
| ZA200300522B | South Africa | B | |
| MXPA03001431A | Mexico | A | |
| LT5138B | Lithuania | B | |
| US2004157897A1 | United States of America | A1 | |
| EE200300063A | Estonia | A | |
| PL365610A1 | Poland | A1 | |
| GEP20053495B | Georgia | B | |
| NZ523722A | New Zealand | A | |
| HU0300826A3 | Hungary | A3 | |
| US6982276B2 | United States of America | B2 | |
| RU2272039C2 | Russian Federation | C2 | |
| US2006063815A1 | United States of America | A1 | |
| UA75365C2 | Ukraine | C2 | |
| CN1269821C | China | C | |
| YU12103A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| USRE39251E | United States of America | E | |
| US7153879B2 | United States of America | B2 | |
| AU2001281082B2 | Australia | B2 | |
| EP1309597B1 | European Patent Office (EPO) | B1 | |
| AT366735T | Austria | T | |
| PT1309597E | Portugal | E | |
| DE60129334D1 | Germany | D1 | |
| DK1309597T3 | Denmark | T3 | |
| MY134129A | Malaysia | A | |
| ES2288518T3 | Spain | T3 | |
| KR100810342B1 | Republic of Korea | B1 | |
| DE60129334T2 | Germany | T2 | |
| IL153993A | Israel | A | |
| SI21100B | Slovenia | B | |
| TWI320040B | Taiwan Province of China | B | |
| EE05273B1 | Estonia | B1 | |
| NO328500B1 | Norway | B1 | |
| PL205628B1 | Poland | B1 | |
| BG66132B1 | Bulgaria | B1 | |
| RO123296B1 | Romania | B1 | |
| HRP20030190B1 | Croatia | B1 | |
| CA2418109C | Canada | C | |
| SK287876B6 | Slovakia | B6 | |
| JP5046467B2 | Japan | B2 | |
| CY1107758T1 | Cyprus | T1 | |
| IS2845B | Iceland | B | |
| HU229314B1 | Hungary | B1 | |
| CZ305523B6 | Czechia | B6 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Lapsed patentsLapsedMM9A | MM9A |
Numbers
- Publication, DOCDB
- 2003017
- Publication, EPODOC
- LT2003017
- Application
- 17
- Application, DOCDB
- 2003017
- Application, EPODOC
- LT20030000017
Titles2
- English
- POLYMORPHS OF AN EPOTHILONE ANALOG
- Lithuanian
- EPOTILONO ANALOGO POLIMORFINĖS FORMOS
Classification
- CPC, 4
- C07D491/04
- C07D417/14
- C07D417/06
- A61P35/00
- IPC, 6
- A61K31 00
- A61P35 00
- C07D417 00
- C07D491 00
- C07D491 04
- C07D491 044